友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
Infection and Drug Resistance
INFECT DRUG RESIST
ISSN / eISSN
1178-6973
目标和范围
About Journal
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
研究方向
传染病学
药学
CiteScore
5.60
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Medicine - Pharmacology (medical) | Q2 | #88/272 |
| Medicine - Infectious Diseases | Q2 | #126/344 |
| Medicine - Pharmacology | Q2 | #134/313 |
Web of Science 核心收藏夹
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2024) | 分区 |
|---|---|
| INFECTIOUS DISEASES | Q2 |
| PHARMACOLOGY & PHARMACY | Q2 |
H-index
27
出版国家或地区
UNITED STATES
出版商
Dove Medical Press Ltd.
年文章数
682
Open Access
YES
通讯方式
PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
认证评论
Peer review completed on January 24th, requested original figures during the process, and changed one reviewer
Made minor revisions on February 1st (Chinese New Year), and returned on the 21st
Returned on February 21st
Accepted on March 9th, paid, a bit expensive
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started